Breaking News Instant updates and real-time market news.

AEZS

Aeterna Zentaris

$0.62 /

-0.091 (-12.80%)

13:02
04/07/20
04/07
13:02
04/07/20
13:02

Aeterna Zentaris says EMA accepts modification to PIP for macimorelin

Aeterna Zentaris announced the decision of the European Medicines Agency to accept a modification request by Aeterna Zentaris of the company's Pediatric Investigation Plan for macimorelin as originally approved in March 2017 which covered the conduct of two pediatric studies and defined relevant key elements in the outline of these studies. The company recently announced the positive results and successful completion of the first of these studies, Study P01. The goal of Study P01 was to establish a dose that could both be safely administered to pediatric patients and cause a clear rise in growth hormone concentration in subjects ultimately diagnosed as not having GHD. The second pediatric study, Study P02, is designed to investigate the diagnostic efficacy and safety of macimorelin acetate in pediatric patients from 2 years of age to 18 years of age with suspected growth hormone deficiency.

TODAY'S FREE FLY STORIES

Recommendations
Burlington Stores price target raised to $250 from $215 at DA Davidson » 08:40
05/29/20
05/29
08:40
05/29/20
08:40
BURL

Burlington Stores

$213.43 /

+3.12 (+1.48%)

DA Davidson analyst Laura…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BURL Burlington Stores
$213.43 /

+3.12 (+1.48%)

BURL Burlington Stores
$213.43 /

+3.12 (+1.48%)

08:06 Today Loop Capital
Burlington Stores price target lowered to $250 from $265 at Loop Capital
06:22 Today Citi
Burlington Stores price target raised to $250 from $205 at Citi
05/11/20 Nomura Instinet
Burlington Stores price target raised to $190 from $170 at Nomura Instinet
03/24/20 Citi
Burlington Stores price target lowered to $205 from $260 at Citi
BURL Burlington Stores
$213.43 /

+3.12 (+1.48%)

BURL Burlington Stores
$213.43 /

+3.12 (+1.48%)

BURL Burlington Stores
$213.43 /

+3.12 (+1.48%)

Recommendations
Marvell price target lowered to $30 from $37 at Craig-Hallum » 08:40
05/29/20
05/29
08:40
05/29/20
08:40
MRVL

Marvell

$29.97 /

-0.72 (-2.35%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$29.97 /

-0.72 (-2.35%)

MRVL Marvell
$29.97 /

-0.72 (-2.35%)

07:37 Today Citi
Marvell stays top specialty semi pick after 'beat and raise' at Citi
04:54 Today Oppenheimer
Marvell price target raised to $35 from $30 at Oppenheimer
05/26/20 Susquehanna
Marvell price target raised to $35 from $30 at Susquehanna
05/22/20 B. Riley FBR
Marvell price target raised to $34 from $31 at B. Riley FBR
MRVL Marvell
$29.97 /

-0.72 (-2.35%)

MRVL Marvell
$29.97 /

-0.72 (-2.35%)

MRVL Marvell
$29.97 /

-0.72 (-2.35%)

MRVL Marvell
$29.97 /

-0.72 (-2.35%)

Hot Stocks
Pareteum receives listing extension from Nasdaq » 08:40
05/29/20
05/29
08:40
05/29/20
08:40
TEUM

Pareteum

$0.44 /

-0.0046 (-1.03%)

Pareteum announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEUM Pareteum
$0.44 /

-0.0046 (-1.03%)

TEUM Pareteum
$0.44 /

-0.0046 (-1.03%)

10/22/19 Lake Street
Pareteum downgraded to Hold from Buy at Lake Street
10/22/19 Northland
Northland cuts Pareteum to Market Perform after 'unusually large' restatement
10/22/19 Oppenheimer
Pareteum downgraded to Perform at Oppenheimer
10/22/19 Oppenheimer
Pareteum downgraded to Perform from Outperform at Oppenheimer
TEUM Pareteum
$0.44 /

-0.0046 (-1.03%)

TEUM Pareteum
$0.44 /

-0.0046 (-1.03%)

Hot Stocks
BeiGene presents updated reslts from Phase 3 trial of zanubrutinib vs. ibrutinib » 08:40
05/29/20
05/29
08:40
05/29/20
08:40
BGNE

BeiGene

$162.99 /

+1.88 (+1.17%)

BeiGene announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BGNE BeiGene
$162.99 /

+1.88 (+1.17%)

BGNE BeiGene
$162.99 /

+1.88 (+1.17%)

03/25/20 Piper Sandler
BeiGene Abraxane issue could take months to resolve, says Piper Sandler
03/13/20 Macquarie
BeiGene upgraded to Neutral from Underperform at Macquarie
03/03/20 Maxim
BeiGene price target lowered to $190 from $210 at Maxim
02/18/20 Goldman Sachs
BeiGene reinstated with a Buy at Goldman Sachs
BGNE BeiGene
$162.99 /

+1.88 (+1.17%)

BGNE BeiGene
$162.99 /

+1.88 (+1.17%)

Downgrade
Monro downgraded to Neutral on slower recovery expectations at Guggenheim » 08:40
05/29/20
05/29
08:40
05/29/20
08:40
MNRO

Monro

$57.75 /

-4.27 (-6.88%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNRO Monro
$57.75 /

-4.27 (-6.88%)

MNRO Monro
$57.75 /

-4.27 (-6.88%)

06:08 Today Guggenheim
Monro downgraded to Neutral from Buy at Guggenheim
04/03/20 SunTrust
Monro price target lowered to $47 from $68 at SunTrust
12/10/19
Fly Intel: Top five analyst upgrades
12/10/19 Guggenheim
Monro upgraded to Buy on store refresh opportunity at Guggenheim
MNRO Monro
$57.75 /

-4.27 (-6.88%)

General news
U.S. equity futures are mostly weaker » 08:40
05/29/20
05/29
08:40
05/29/20
08:40

U.S. equity futures are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Resideo names Tony Trunzo as CFO, effective June 8 » 08:39
05/29/20
05/29
08:39
05/29/20
08:39
REZI

Resideo

$6.56 /

-0.22 (-3.24%)

Resideo announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REZI Resideo
$6.56 /

-0.22 (-3.24%)

REZI Resideo
$6.56 /

-0.22 (-3.24%)

04/28/20 Imperial Capital
Resideo downgraded to In-Line from Outperform at Imperial Capital
04/03/20
Fly Intel: Top five analyst initiations
04/03/20 Roth Capital
Resideo initiated with a Neutral at Roth Capital
02/28/20 Imperial Capital
Resideo upgraded to Outperform from In-Line at Imperial Capital
REZI Resideo
$6.56 /

-0.22 (-3.24%)

Hot Stocks
Celsion DSMB recommends to proceed to Phase II of the Ovation 2 study » 08:38
05/29/20
05/29
08:38
05/29/20
08:38
CLSN

Celsion

$2.95 /

+0.04 (+1.37%)

Celsion announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLSN Celsion
$2.95 /

+0.04 (+1.37%)

CLSN Celsion
$2.95 /

+0.04 (+1.37%)

Hot Stocks
Seattle Genetics announces results from exploratory analyses of HER2CLIMB trial » 08:38
05/29/20
05/29
08:38
05/29/20
08:38
SGEN

Seattle Genetics

$151.77 /

-1.21 (-0.79%)

Seattle Genetics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGEN Seattle Genetics
$151.77 /

-1.21 (-0.79%)

SGEN Seattle Genetics
$151.77 /

-1.21 (-0.79%)

05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy on raised PADCEV estimates at Goldman Sachs
05/26/20 JMP Securities
Seattle Genetics initiated with an Outperform at JMP Securities
05/26/20 Goldman Sachs
Incyte downgraded to Buy from Conviction Buy at Goldman Sachs
05/26/20 Goldman Sachs
Seattle Genetics upgraded to Conviction Buy from Buy at Goldman Sachs
SGEN Seattle Genetics
$151.77 /

-1.21 (-0.79%)

SGEN Seattle Genetics
$151.77 /

-1.21 (-0.79%)

Initiation
Twilio assumed with a Buy at Canaccord » 08:37
05/29/20
05/29
08:37
05/29/20
08:37
TWLO

Twilio

$191.59 /

-0.55 (-0.29%)

Canaccord analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWLO Twilio
$191.59 /

-0.55 (-0.29%)

TWLO Twilio
$191.59 /

-0.55 (-0.29%)

07:41 Today Cowen
Twilio price target raised to $230 from $180 at Cowen
05/27/20 RBC Capital
Twilio price target raised to $240 from $180 at RBC Capital
05/26/20 Needham
Twilio price target raised to $225 from $170 at Needham
05/20/20 JMP Securities
Twilio price target raised to $200 from $160 at JMP Securities
TWLO Twilio
$191.59 /

-0.55 (-0.29%)

TWLO Twilio
$191.59 /

-0.55 (-0.29%)

TWLO Twilio
$191.59 /

-0.55 (-0.29%)

TWLO Twilio
$191.59 /

-0.55 (-0.29%)

Recommendations
Dollar Tree price target raised to $110 from $90 at KeyBanc » 08:37
05/29/20
05/29
08:37
05/29/20
08:37
DLTR

Dollar Tree

$97.64 /

+10.21 (+11.68%)

KeyBanc analyst Bradley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

08:36 Today Loop Capital
Dollar Tree price target raised to $90 from $74 at Loop Capital
06:36 Today Credit Suisse
Dollar Tree price target raised to $107 from $98 at Credit Suisse
06:15 Today Citi
Dollar Tree price target raised to $115 from $103 at Citi
05/28/20 Wells Fargo
Dollar Tree price target raised to $125 from $97 at Wells Fargo
DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

Recommendations
Ulta Beauty price target raised to $270 from $250 at Guggenheim » 08:37
05/29/20
05/29
08:37
05/29/20
08:37
ULTA

Ulta Beauty

$243.36 /

-8.48 (-3.37%)

Guggenheim analyst Steven…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

07:44 Today Cowen
Ulta Beauty price target raised to $280 from $235 at Cowen
07:27 Today Oppenheimer
Ulta Beauty price target raised to $270 from $240 at Oppenheimer
06:29 Today Wells Fargo
Ulta Beauty price target raised to $300 from $250 at Wells Fargo
05/12/20 Cleveland Research
Ulta Beauty lost share to Target and Sephoria, says Cleveland Research
ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

Hot Stocks
Cardiff Oncology presents new data from Phase 1b/2 trial of onvansertib » 08:37
05/29/20
05/29
08:37
05/29/20
08:37
CRDF

Cardiff Oncology

$2.47 /

+0.17 (+7.39%)

Cardiff Oncology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRDF Cardiff Oncology
$2.47 /

+0.17 (+7.39%)

Recommendations
Dollar Tree price target raised to $90 from $74 at Loop Capital » 08:36
05/29/20
05/29
08:36
05/29/20
08:36
DLTR

Dollar Tree

$97.64 /

+10.21 (+11.68%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

06:36 Today Credit Suisse
Dollar Tree price target raised to $107 from $98 at Credit Suisse
06:15 Today Citi
Dollar Tree price target raised to $115 from $103 at Citi
05/28/20 Wells Fargo
Dollar Tree price target raised to $125 from $97 at Wells Fargo
05/26/20 Deutsche Bank
Dollar Tree price target raised to $97 from $87 at Deutsche Bank
DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

DLTR Dollar Tree
$97.64 /

+10.21 (+11.68%)

Hot Stocks
Syros Pharmaceuticals presents new preclinical data for SY-5609 at ASCO » 08:36
05/29/20
05/29
08:36
05/29/20
08:36
SYRS

Syros Pharmaceuticals

$9.52 /

-0.24 (-2.46%)

Syros Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYRS Syros Pharmaceuticals
$9.52 /

-0.24 (-2.46%)

SYRS Syros Pharmaceuticals
$9.52 /

-0.24 (-2.46%)

04/23/20 JonesTrading
Syros Pharmaceuticals initiated with a Buy at JonesTrading
03/06/20 H.C. Wainwright
Syros Pharmaceuticals price target lowered to $8 from $10 at H.C. Wainwright
01/17/20 Wedbush
Syros Pharmaceuticals risk/reward balanced ahead of data readouts, says Wedbush
01/17/20 Wedbush
Syros Pharmaceuticals downgraded to Neutral from Outperform at Wedbush
SYRS Syros Pharmaceuticals
$9.52 /

-0.24 (-2.46%)

General news
International Trade in Goods Balance data reported » 08:35
05/29/20
05/29
08:35
05/29/20
08:35

April International Trade…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Dollar General price target raised to $210 from $200 at KeyBanc » 08:35
05/29/20
05/29
08:35
05/29/20
08:35
DG

Dollar General

$184.09 /

-2.715 (-1.45%)

KeyBanc analyst Bradley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

08:23 Today BMO Capital
Dollar General price target raised to $200 from $175 at BMO Capital
08:20 Today Loop Capital
Dollar General price target raised to $190 from $175 at Loop Capital
05/28/20 Wells Fargo
Wells says Dollar General 'in a league of its own' after 'standout quarter'
05/26/20 Deutsche Bank
Dollar General price target raised to $187 from $159 at Deutsche Bank
DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

Recommendations
Toll Brothers price target raised to $36 from $27 at Keefe Bruyette » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
TOL

Toll Brothers

$32.30 /

-0.65 (-1.97%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

07:09 Today RBC Capital
Toll Brothers price target raised to $37 from $31 at RBC Capital
05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

Hot Stocks
Heat Biologics presents HS-110/Opdivo combination Phase 2 trial data at ASCO » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
HTBX

Heat Biologics

$1.11 /

+0.156 (+16.35%)

, BMY

Bristol-Myers

$59.80 /

-0.59 (-0.98%)

Heat Biologics (HTBX)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HTBX Heat Biologics
$1.11 /

+0.156 (+16.35%)

BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

HTBX Heat Biologics
$1.11 /

+0.156 (+16.35%)

03/05/20 Maxim
Heat Biologics price target raised to $2 at Maxim after COVID-19 vaccine deal
02/06/20 Maxim
Heat Biologics initiated with a Buy at Maxim
02/06/20 Maxim
Heat Biologics initiated with a Buy at Maxim
07/29/19 Brookline
Heat Biologics initiated with a Buy at Brookline
BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
05/13/20 Piper Sandler
Bluebird should be able to easily address RTF issues, says Piper Sandler
05/12/20 Oppenheimer
Bluebird Bio price target lowered to $111 from $122 at Oppenheimer
04/20/20 Piper Sandler
Exelixis combo approval would increase kidney cancer use, says Piper Sandler
BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

Hot Stocks
AcelRx raises consideration to acquire Tetraphase » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
ACRX

AcelRx

$1.50 /

-0.055 (-3.55%)

, TTPH

Tetraphase

$2.24 /

+0.04 (+1.82%)

AcelRx Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACRX AcelRx
$1.50 /

-0.055 (-3.55%)

TTPH Tetraphase
$2.24 /

+0.04 (+1.82%)

ACRX AcelRx
$1.50 /

-0.055 (-3.55%)

05/07/20 Gabelli
Tetraphase upgraded to Hold from Sell at Gabelli
03/17/20 H.C. Wainwright
AcelRx price target lowered to $7 from $9 at H.C. Wainwright
03/17/20 Gabelli
Tetraphase downgraded to Sell from Hold at Gabelli
11/11/19 Credit Suisse
Credit Suisse downgrades AcelRx to Neutral, cuts target to $2 from $7
TTPH Tetraphase
$2.24 /

+0.04 (+1.82%)

05/07/20 Gabelli
Tetraphase upgraded to Hold from Sell at Gabelli
03/17/20 H.C. Wainwright
AcelRx price target lowered to $7 from $9 at H.C. Wainwright
03/17/20 Gabelli
Tetraphase downgraded to Sell from Hold at Gabelli
01/24/20 Gabelli
Tetraphase downgraded to Hold on fundraising dilution at Gabelli
ACRX AcelRx
$1.50 /

-0.055 (-3.55%)

ACRX AcelRx
$1.50 /

-0.055 (-3.55%)

TTPH Tetraphase
$2.24 /

+0.04 (+1.82%)

Hot Stocks
Defense Innovation Unit picks Zscaler for secure cloud management project » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
ZS

Zscaler

$75.88 /

+1.34 (+1.80%)

Zscaler announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

08:16 Today DA Davidson
Zscaler price target raised to $105 from $65 at DA Davidson
07:39 Today Cowen
Zscaler price target raised to $100 from $80 at Cowen
07:16 Today Wedbush
Zscaler price target raised to $100 from $80 at Wedbush
06:32 Today Credit Suisse
Zscaler price target raised to $90 from $75 at Credit Suisse
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

Earnings
Humana reaffirms FY20 adjusted EPS view of $18.25-$18.75, consensus $18.54 » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
HUM

Humana

$403.99 /

+4.315 (+1.08%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$403.99 /

+4.315 (+1.08%)

HUM Humana
$403.99 /

+4.315 (+1.08%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
HUM Humana
$403.99 /

+4.315 (+1.08%)

HUM Humana
$403.99 /

+4.315 (+1.08%)

HUM Humana
$403.99 /

+4.315 (+1.08%)

HUM Humana
$403.99 /

+4.315 (+1.08%)

Initiation
Everbridge assumed with a Buy at Canaccord » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
EVBG

Everbridge

$137.04 /

-1.27 (-0.92%)

Canaccord analyst T.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVBG Everbridge
$137.04 /

-1.27 (-0.92%)

EVBG Everbridge
$137.04 /

-1.27 (-0.92%)

05/20/20 Stifel
Everbridge price target raised to $160 from $130 at Stifel
05/06/20 Canaccord
Everbridge price target raised to $135 from $125 at Canaccord
05/06/20 Baird
Everbridge price target raised to $132 from $120 at Baird
05/06/20 Credit Suisse
Everbridge price target raised to $118 from $95 at Credit Suisse
EVBG Everbridge
$137.04 /

-1.27 (-0.92%)

Conference/Events
Amgen to host conference call » 08:33
05/29/20
05/29
08:33
05/29/20
08:33
AMGN

Amgen

$224.02 /

-0.79 (-0.35%)

Research &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$224.02 /

-0.79 (-0.35%)

AMGN Amgen
$224.02 /

-0.79 (-0.35%)

05/28/20 Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/28/20 Cowen
Alexion settlement may yield upside surprise, says Cowen
05/28/20 Stifel
Alexion, Amgen appear to have agreed to settlement deal, says Stifel
05/22/20 Piper Sandler
Harpoon Therapeutics initiated with an Overweight at Piper Sandler
AMGN Amgen
$224.02 /

-0.79 (-0.35%)

AMGN Amgen
$224.02 /

-0.79 (-0.35%)

AMGN Amgen
$224.02 /

-0.79 (-0.35%)

Hot Stocks
NovaGold calls short seller report 'misleading', 'inaccurate' » 08:33
05/29/20
05/29
08:33
05/29/20
08:33
NG

NovaGold

$9.73 /

-0.915 (-8.60%)

NOVAGOLD RESOURCES…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NG NovaGold
$9.73 /

-0.915 (-8.60%)

NG NovaGold
$9.73 /

-0.915 (-8.60%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.